Aromatic Plant Oils of the Peruvian Amazon. Part 2.Cymbopogon citratus(DC) Stapf.,Renealmiasp.,Hyptis recurvataPoit. andTynanthus panurensis(Bur.) Sandw

Chemical composition and antioxidant activity of the essential oil of Renealmia alpinia (Rottb.) Maas

Renealmia alpinia (Rottb.) Maas was collected in Serra do Tepequém, municipality of Amajari, state of Roraima, Brazil. The essential oil was obtained from the fresh leaves by hydrodistillation using a Clevenger apparatus and analysed using GC-FID and GC-MS. The oil provided a yield of 0.6% (w/w), which, in the analysis of its contents, presented a higher concentration of sesquiterpenes, with α-phellandrene (23.10%), 16-oxo-8(17),12(E)-labdadien-15-oic acid (17.05%), β-caryophyllene (10.28%), valencene (5.27%) and allo-aromadendrene (3.52%) being the most abundant. The antioxidant activity of the essential oil was determined using two methods, and indicated significant activity by both. Using the DPPH method, the essential oil presented an IC50 of 1.470 ± 0.0264 mg.L1 and an inhibition of the β-carotene/linoleic acid oxidation system of 76.43 ± 0.80%.

COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

BACKGROUND

Current recommendations for the self-management of SARS-Cov-2 disease (COVID-19) include self-isolation, rest, hydration, and the use of NSAID in case of high fever only. It is expected that many patients will add other symptomatic/adjuvant treatments, such as herbal medicines.

AIMS

To provide a benefits/risks assessment of selected herbal medicines traditionally indicated for "respiratory diseases" within the current frame of the COVID-19 pandemic as an adjuvant treatment.

METHOD

The plant selection was primarily based on species listed by the WHO and EMA, but some other herbal remedies were considered due to their widespread use in respiratory conditions. Preclinical and clinical data on their efficacy and safety were collected from authoritative sources. The target population were adults with early and mild flu symptoms without underlying conditions. These were evaluated according to a modified PrOACT-URL method with paracetamol, ibuprofen, and codeine as reference drugs. The benefits/risks balance of the treatments was classified as positive, promising, negative, and unknown.

RESULTS

A total of 39 herbal medicines were identified as very likely to appeal to the COVID-19 patient. According to our method, the benefits/risks assessment of the herbal medicines was found to be positive in 5 cases (Althaea officinalis, Commiphora molmol, Glycyrrhiza glabra, Hedera helix, and Sambucus nigra), promising in 12 cases (Allium sativum, Andrographis paniculata, Echinacea angustifolia, Echinacea purpurea, Eucalyptus globulus essential oil, Justicia pectoralis, Magnolia officinalis, Mikania glomerata, Pelargonium sidoides, Pimpinella anisum, Salix sp, Zingiber officinale), and unknown for the rest. On the same grounds, only ibuprofen resulted promising, but we could not find compelling evidence to endorse the use of paracetamol and/or codeine.

CONCLUSIONS

Our work suggests that several herbal medicines have safety margins superior to those of reference drugs and enough levels of evidence to start a clinical discussion about their potential use as adjuvants in the treatment of early/mild common flu in otherwise healthy adults within the context of COVID-19. While these herbal medicines will not cure or prevent the flu, they may both improve general patient well-being and offer them an opportunity to personalize the therapeutic approaches.

On the Possible Chemical Justification of the Ethnobotanical Use of Hyptis obtusiflora in Amazonian Ecuador

In rural areas of Latin America, Hyptis infusions are very popular. Hyptis obtusiflora extends from Mexico throughout Central America to Bolivia and Peru. It has added value in Ecuador where it has been used by different ethnic groups. We aimed to learn about the traditional knowledge of ancient Kichwa cultures about this plant, and to contrast this knowledge with the published information organized in occidental databases. We proposed to use traditional knowledge as a source of innovation for social development. Our specific objectives were to catalogue the uses of H. obtusiflora in the community, to prospect on the bibliography on a possible chemical justification for its medicinal use, to propose new products for development, and to give arguments for biodiversity conservation. An ethnobotanical survey was made and a Prisma 2009 Flow Diagram was then followed for scientific validation. We rescued data that are novel contributions for the ethnobotany at the national level. The catalogued main activity of anti-inflammation can be related to the terpene composition and the inhibition of xanthine oxidase. This opens the possibility of researching the extract of this plant as an alternative to allopurinol or uricosuric drugs. This is a concrete example of an argument for biodiversity conservation.

Essential Oils from the Hyptis genus- A Review (1909-2009)

Several species belonging to the Hyptis (Lamiaceae) genus represent an important source of bioactive constituents, which are reputed for their wide range of antimicrobial, anticancer and insecticidal activities. The volatile oils obtained from various parts of the Hyptis plants were found to be primarily composed of mono- and sesquiterpenes. Significant differences were observed in the percentage compositions of the major components, which allowed for differentiation among the species. Based on the dominant constituents, phylogenetic relationships were found to be common among some species: 1,8-cineole ( H. fruticosa, H. goyazensis, H. martiusii and H. suaveolens); β-caryophyllene ( H. marrubioides, H. pectinata, H. spicigera and H. suaveolens); eugenol ( H. recurvata and H. suaveolens); γ-cadinene ( H. glomerata and H. ovalifolia); p-cymene ( H. mutabilis and H. pectinata); α-pinene ( H. crenata and H. emoryi). The monoterpenes, α-pinene and p-cymene were detected at various concentrations in all the Hyptis oils investigated. This paper reviews the essential oil compositions of eighteen Hyptis plant species studied in various parts of the world covering the publications of 100 years (1909 to 2009) after the first article appeared in the literature.